Did You Know?

Editor’s Picks

Latest News

Aytu BioScience Submits Notice of Commercialization to the FDA, Allowing for Company’s Distribution of its 2-10 Minute COVID-19 IgG/IgM Point-of-Care Rapid Test

Commercial Distribution of First 100,000 Tests to Commence Upon Receipt of Inbound Product Shipment ENGLEWOOD, CO / ACCESSWIRE / March...

In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic

error: Content is protected !!